Risks associated with the therapeutic use of fluoroquinolones

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.4, 2013-07, pp. : 497-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cerebrovascular risks associated with tamoxifen use

By Bushnell Cheryl

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Characterization of Risks Associated with the Use of Molinate

By Cochran R.C. Formoli T.A. Pfeifer K.F. Aldous C.N.

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 2, 1997-04 ,pp. : 146-157

Academic Press

Access to resources Recommend Favorite

Therapeutic advances of new fluoroquinolones

By Ball P. Fernald A. Tillotson G.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 761-783

Informa Healthcare

Access to resources Recommend Favorite

The use of fluoroquinolones in the treatment of skin infections

By Martin Steven J Zeigler Dustin G

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 237-246

Informa Healthcare

Access to resources Recommend Favorite

Fatalities Associated with Therapeutic Use and Overdose of Atypical Antipsychotics

By Trenton A.J.

CNS Drugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 307-324

Adis International

Access to resources Recommend Favorite